Additionally, RASAL2 (RAS protein activator like 2) inhibited tumor angiogenesis via p-AKT/ETS1 (ETS proto-oncogene 1, transcription factor) signaling in bladder cancer [27]. This evidence concerns the gene RASAL2 and urinary bladder carcinoma.